BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29563804)

  • 1. Decreased expression of LKB1 predicts poor prognosis in pancreatic neuroendocrine tumor patients undergoing curative resection.
    Li D; Zhou Y; Liu Y; Lin Y; Yu M; Lu X; Huang B; Sun Z; Jian Z; Hou B
    Onco Targets Ther; 2018; 11():1259-1265. PubMed ID: 29563804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The regulatory role of aberrant Phosphatase and Tensin Homologue and Liver Kinase B1 on AKT/mTOR/c-Myc axis in pancreatic neuroendocrine tumors.
    Chang TM; Shan YS; Chu PY; Jiang SS; Hung WC; Chen YL; Tu HC; Lin HY; Tsai HJ; Chen LT
    Oncotarget; 2017 Nov; 8(58):98068-98083. PubMed ID: 29228674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour stem cell markers CD133 and CD44 are useful prognostic factors after surgical resection of pancreatic neuroendocrine tumours.
    Sun Z; Li D; Wu H; Hou B
    Oncol Lett; 2020 Dec; 20(6):341. PubMed ID: 33123252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of LKB1 promotes tumor progression and predicts unfavorable prognosis in patients with glioma.
    Huang J; Chen H; Wei Q; Zhang Z; Zhong Z; Xu Y
    Oncol Lett; 2017 Mar; 13(3):1688-1694. PubMed ID: 28454310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low LKB1 Expression Results in Unfavorable Prognosis in Prostate Cancer Patients.
    Lu J; Sun P; Sun B; Wang C
    Med Sci Monit; 2015 Nov; 21():3722-7. PubMed ID: 26616116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma.
    Yang JY; Jiang SH; Liu DJ; Yang XM; Huo YM; Li J; Hua R; Zhang ZG; Sun YW
    Sci Rep; 2015 May; 5():10575. PubMed ID: 26015068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of the preoperative main pancreatic duct dilation and neutrophil-to-lymphocyte ratio in pancreatic neuroendocrine tumors (PNETs) of the head after curative resection.
    Zhou B; Zhan C; Xiang J; Ding Y; Yan S
    BMC Endocr Disord; 2019 Nov; 19(1):123. PubMed ID: 31718651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High vimentin expression with E-cadherin expression loss predicts a poor prognosis after resection of grade 1 and 2 pancreatic neuroendocrine tumors.
    Zhou B; Xiang J; Jin M; Zheng X; Li G; Yan S
    BMC Cancer; 2021 Mar; 21(1):334. PubMed ID: 33789624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of LKB1 Expression Decreases the Survival and Promotes Laryngeal Cancer Metastasis.
    He SS; Chen Y; Wang HZ; Shen XM; Sun P; Dong J; Liao XB; Guo GF; Chen JG; Xia LP; Hu PL; Qiu HJ; Liu SS; Zhou YX; Wang W; Hu WH; Cai XY
    J Cancer; 2017; 8(17):3548-3554. PubMed ID: 29151940
    [No Abstract]   [Full Text] [Related]  

  • 10. Association between LKB1 expression and prognosis of patients with solid tumours: an updated systematic review and meta-analysis.
    Ren YH; Zhao FJ; Mo HY; Jia RR; Tang J; Zhao XH; Wei JL; Huo RR; Li QQ; You XM
    BMJ Open; 2019 Aug; 9(8):e027185. PubMed ID: 31383697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors of long-term outcome in surgically resectable pancreatic neuroendocrine tumors: A 12-year experience from a single center.
    Zhou B; Duan J; Yan S; Zhou J; Zheng S
    Oncol Lett; 2017 Mar; 13(3):1157-1164. PubMed ID: 28454228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of LKB1 is associated with epithelial-mesenchymal transition and led to an unfavorable prognosis in gastric cancer.
    Hu M; Zhao T; Liu J; Zou Z; Xu Q; Gong P; Guo H
    Hum Pathol; 2019 Jan; 83():133-139. PubMed ID: 30171989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic value of tumor infiltration immune cells in pancreatic cancer].
    Zhao KL; Liu J; Jiang WN; Hao JH
    Zhonghua Wai Ke Za Zhi; 2018 Jun; 56(6):464-470. PubMed ID: 29886672
    [No Abstract]   [Full Text] [Related]  

  • 15. Upregulation of liver kinase B1 predicts poor prognosis in hepatocellular carcinoma.
    Tan X; Liao Z; Liang H; Chen X; Zhang B; Chu L
    Int J Oncol; 2018 Nov; 53(5):1913-1926. PubMed ID: 30226588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer.
    Jiang L; Liang X; Liu M; Wang W; Ma J; Guo Q; Han L; Yang C; Nan K
    Oncol Rep; 2014 Nov; 32(5):1931-8. PubMed ID: 25175672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological significance of ISYNA1 expression in pancreatic ductal adenocarcinoma].
    Zhou L; Sheng WW; Shi XY; Zhou JP; Dong M
    Zhonghua Wai Ke Za Zhi; 2019 Mar; 57(3):206-211. PubMed ID: 30861650
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation.
    Chen J; Yang Y; Liu Y; Kan H
    World J Surg Oncol; 2021 Jan; 19(1):11. PubMed ID: 33436017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical resection of primary tumor is associated with prolonged survival in low-grade pancreatic neuroendocrine tumors.
    Sun Y; Wang Y; Li R; Kang G; Zhang M; Chen X; Jin M; Liu Y; He Y; Zhu X; Kang Q; Zhou F; Yu Q
    Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101432. PubMed ID: 32386797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis.
    Xiao J; Zou Y; Chen X; Gao Y; Xie M; Lu X; Li W; He B; He S; You S; Chen Q
    PLoS One; 2016; 11(4):e0152674. PubMed ID: 27035914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.